Disc Medicine, Inc. (IRON) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Watertown, MA, アメリカ. 現CEOは John D. Quisel.
IRON を有する IPO日 2020-08-12, 94 名の正社員, に上場 NASDAQ Global Market, 時価総額 $2.69B.
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
